Cargando…
Syndecan-3 as a Novel Biomarker in Alzheimer’s Disease
Early diagnosis of Alzheimer’s disease (AD) is of paramount importance in preserving the patient’s mental and physical health in a fairly manageable condition for a longer period. Reliable AD detection requires novel biomarkers indicating central nervous system (CNS) degeneration in the periphery. M...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955174/ https://www.ncbi.nlm.nih.gov/pubmed/35328830 http://dx.doi.org/10.3390/ijms23063407 |